|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Ramipril#Patient Counseling Information]] |
| {{Ramipril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==Patient Counseling Information==
| |
| | |
| ====Angioedema====
| |
| [[Angioedema]], including laryngeal edema, can occur rarely with treatment with ACE inhibitors, especially following the first dose. Advise patients to report immediately any signs or symptoms suggesting angioedema (swelling of face, eyes, lips, or tongue, or difficulty in breathing) and to take no more drug until they have consulted with the prescribing physician.
| |
| | |
| ====Neutropenia====
| |
| Advise patients to report promptly any indication of infection (e.g., [[sore throat]], [[fever]]), which could be a sign of [[neutropenia]].
| |
| | |
| ====Symptomatic Hypotension====
| |
| Inform patients that [[light-headedness]] can occur, especially during the first days of therapy, and it should be reported. Advise patients to discontinue ALTACE if syncope (fainting) occurs, and to follow up with their health care providers.
| |
| | |
| Inform patients that inadequate fluid intake or excessive perspiration, [[diarrhea]], or [[vomiting]] while taking ALTACE can lead to an excessive fall in blood pressure, with the same consequences of [[lightheadedness]] and possible [[syncope]].
| |
| | |
| ====Pregnancy====
| |
| Female patients of childbearing age should be told about the consequences of exposure to Altace during pregnancy. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.
| |
| | |
| | |
| ====Hyperkalemia====
| |
| Advise patients not to use salt substitutes containing [[potassium]] without consulting their physician.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |